Advertisement

U.S. Markets open in 5 hrs 6 mins

S&P Futures
4,032.25
+30.75(+0.77%)
Dow Futures
32,761.00
+173.00(+0.53%)
Nasdaq Futures
12,836.75
+104.25(+0.82%)
Russell 2000 Futures
1,782.20
+17.40(+0.99%)
Crude Oil
73.68
+0.48(+0.66%)
Gold
1,962.70
-10.80(-0.55%)

Advertisement

JAGX Jan 2024 0.500 put

OPR - OPR Delayed Price. Currency in USD

0.3000

0.0000

(0.00%)

As of 12:35PM EDT. Market open.

Advertisement

Loading interactive chart...

ACCESSWIRE
Jaguar Health Reports 2022 Financial Results - Prescription Revenues up 179% to $11.9 Million
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today provided Company updates and reported consolidated financial results for the year ended December 31, 2022.
ACCESSWIRE
Jaguar Health Announces Time Change for March 27th Investor Webcast to 8:00 AM EDT
Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company investor webcast scheduled for Monday, March 27, 2023 to review fourth-quarter 2022 financials and provide corporate updates will now take place at 8:00 a.m.
ACCESSWIRE
Leading Cancer Patient Advocate Kelly Shanahan, M.D., Joins Jaguar Health's Scientific Advisory Board
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") and its wholly owned subsidiary Napo Pharmaceuticals (Napo) today announced that Dr. Kelly Shanahan, a former clinician and a metastatic breast cancer patient who is now a full-time independent patient advocate, has joined the Jaguar/Napo Scientific Advisory Board (SAB).

Advertisement